King, J.L.; Valdivia, A.; Hingtgen, S.D.; Benhabbour, S.R.
Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study. Pharmaceutics 2025, 17, 3.
https://doi.org/10.3390/pharmaceutics17010003
AMA Style
King JL, Valdivia A, Hingtgen SD, Benhabbour SR.
Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study. Pharmaceutics. 2025; 17(1):3.
https://doi.org/10.3390/pharmaceutics17010003
Chicago/Turabian Style
King, Jasmine L., Alain Valdivia, Shawn D. Hingtgen, and S. Rahima Benhabbour.
2025. "Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study" Pharmaceutics 17, no. 1: 3.
https://doi.org/10.3390/pharmaceutics17010003
APA Style
King, J. L., Valdivia, A., Hingtgen, S. D., & Benhabbour, S. R.
(2025). Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study. Pharmaceutics, 17(1), 3.
https://doi.org/10.3390/pharmaceutics17010003